Evidence map›Paper›PMID 18078988›Full record

ArticleBiomaterials2008

The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes.

Anik Désormeaux, Marie Eve Moreau, Yves Lepage, Jacques Chanard, Albert Adam

Abstract read
In one paragraph

Article in Biomaterials, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Observational
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Haemodialysis membranes.Nature reviews. Nephrology · 2018
    Review
  12. Article
  13. Section 5: Dialysis Interventions for Treatment of AKI.Kidney international supplements · 2012
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Anik DésormeauxFaculty of Pharmacy, Université de Montréal, Montréal, Québec, Canada.
Marie Eve Moreau
Yves Lepage
Jacques Chanard
Albert Adam
Université de Montréal · CAUniversité de Reims Champagne-Ardenne · FR

Funding

Pharmacogenetics of ACE inhibitor-associated angioedema R01HL079184 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BROWN, NANCY J. · 2005 to 2014
$3.2M
NHLBI NIH HHS 1 R01 HL 079184NHLBI NIH HHS R01 HL079184
6 · The paper itself

Abstract

The combination of negatively-charged membranes and angiotensin I-converting enzyme inhibitors (ACEi) evokes hypersensitivity reactions (HSR) during hemodialysis and bradykinin (BK)-related peptides have been hypothesized as being responsible for these complications. In this study, we tested the effects of neutralizing the membrane electronegativity (zeta potential) of polyacrylonitrile AN69 membranes by coating a polyethyleneimine layer (AN69-ST membranes) over the generation of kinins induced by blood contact with synthetic membranes. We used minidialyzers with AN69 or AN69-ST membranes in an ex vivo model of plasma and we showed that plasma dialysis with AN69 membranes led to significant BK and des-Arg(9)-BK release, which was potentiated by ACEi. This kinin formation was dramatically decreased by AN69-ST membranes, even in the presence of an ACEi, and kinin recovery in the dialysates was also significantly lower with these membranes. High molecular weight kininogen and factor XII detection by immunoblotting of the protein layer coating both membranes corroborated the results: binding of these proteins and contact system activation on AN69-ST membranes were reduced. This ex vivo experimental model applied to the plasma, dialysate and dialysis membrane could be used for the characterization of the kinin-forming capacity of any biomaterial potentially used in vivo in combination with drugs which modulate the pharmacological activity of kinins.

Indexed as

Acrylic ResinsMembranes, ArtificialAcrylonitrileAngiotensin-Converting Enzyme InhibitorsBradykininElectrochemistryFemaleHumansIn Vitro TechniquesKininsMaleMaterials TestingMembrane PotentialsRenal DialysisAcrylic ResinsAcrylonitrileAN-69Angiotensin-Converting Enzyme InhibitorsBradykininbradykinin, des-Arg(9)-KininsMembranes, Artificial

Identifiers

PMID18078988
PMCPMC4125129
OpenAlexW1984465728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.